semaglutide measurements Weight loss drug shown to be safe and potentially more effective at higher dose – new findings Semaglutide Dosage Chart for Weight

In this double-blind trial of 1,961 adults with a body mass index (BMI) of 30 or higher, adults on high dose 2.4 mg of weekly semaglutide (compared with the usual type 2 diabetes dose of 0.5mg or 1mg) lost an average 14.9% of baseline body weight after 68 weeks of treatment versus only 2.4% for a group on placebo and lifestyle intervention alone

Its an area of active research, with studies being done to support these initial benefits and reveal new ones.

The company recently suspended its dividend, though, and announced that it has invested $20 million in a virtual primary care service (LifeMD) so that its clients could be prescribed GLP-1 drugs in addition to nutritional and diet products from Medifast

Commenting on the newly published data, Richard E